CT
VRTX icon

Coastline Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Coastline Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Hold
537
– – 0.02% 189
2026
Q1 		$240K Sell
537
-60
-10% -$28K 0.02% 195
2025
Q4 		$271K Hold
597
– – 0.03% 192
2025
Q3 		$234K Sell
597
-3,145
-84% -$1.31M 0.03% 187
2025
Q2 		$1.67M Hold
3,742
– – 0.19% 92
2025
Q1 		$1.81M Buy
3,742
+225
+6% +$105K 0.23% 89
2024
Q4 		$1.42M Sell
3,517
-3,062
-47% -$1.42M 0.17% 105
2024
Q3 		$3.06M Buy
6,579
+760
+13% +$365K 0.36% 61
2024
Q2 		$2.73M Buy
5,819
+20
+0.3% +$8.68K 0.32% 71
2024
Q1 		$2.42M Buy
5,799
+4,784
+471% +$2.02M 0.29% 79
2023
Q4 		$413K Buy
+1,015
New +$375K 0.05% 203
2020
Q4 		– Sell
-1,150
Closed -$313K – 324
2020
Q3 		$313K Sell
1,150
-400
-26% -$110K 0.05% 264
2020
Q2 		$450K Hold
1,550
– – 0.07% 243
2020
Q1 		$369K Hold
1,550
– – 0.07% 246
2019
Q4 		$339K Sell
1,550
-9
-0.6% -$1.82K 0.05% 282
2019
Q3 		$264K Buy
+1,559
New +$276K 0.04% 292

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Coastline Trust's VRTX Position: Q2 2026 in Review

Coastline Trust held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 537 shares worth $267K. The position accounts for 0.02% of the portfolio, ranked #189.

Coastline Trust first reported a position in VRTX in Q3 2019 and has held it in 16 quarters since. The position peaked at $3.06M in Q3 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Coastline Trust held 537 shares of Vertex Pharmaceuticals worth $267K as of Q2 2026.
  • Coastline Trust left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.02% of Coastline Trust's portfolio in Q2 2026, its #189 holding.
  • Coastline Trust first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 16 quarters since.
  • Coastline Trust's Vertex Pharmaceuticals position peaked at $3.06M in Q3 2024.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Coastline Trust's 13F filing for Q2 2026, filed 14 Aug 2026.